These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1718874)

  • 41. Development of monoclonal antibodies suitable for use in antigen quantification potency tests for clostridial veterinary vaccines.
    Hauer PJ; Clough NE
    Dev Biol Stand; 1999; 101():85-94. PubMed ID: 10566780
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The C-terminal domain of Clostridium perfringens alpha toxin as a vaccine candidate against bovine necrohemorrhagic enteritis.
    Goossens E; Verherstraeten S; Valgaeren BR; Pardon B; Timbermont L; Schauvliege S; Rodrigo-Mocholí D; Haesebrouck F; Ducatelle R; Deprez PR; Van Immerseel F
    Vet Res; 2016 Apr; 47(1):52. PubMed ID: 27121298
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epitope mapping of monoclonal antibodies capable of neutralizing cytotoxic necrotizing factor type 1 of uropathogenic Escherichia coli.
    Meysick KC; Mills M; O'Brien AD
    Infect Immun; 2001 Apr; 69(4):2066-74. PubMed ID: 11254559
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The carboxy-terminal C2-like domain of the alpha-toxin from Clostridium perfringens mediates calcium-dependent membrane recognition.
    Guillouard I; Alzari PM; Saliou B; Cole ST
    Mol Microbiol; 1997 Dec; 26(5):867-76. PubMed ID: 9426125
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mapping of the continuous epitopes displayed on the Clostridium perfringens type D epsilon-toxin.
    Alves GG; Machado-de-Ávila RA; Chávez-Olórtegui CD; Silva ROS; Lobato FCF
    Braz J Microbiol; 2017; 48(3):570-575. PubMed ID: 28223027
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficient generation of a reshaped human mAb specific for the alpha toxin of Clostridium perfringens.
    Tempest PR; White P; Williamson ED; Titball RW; Kelly DC; Kemp GJ; Gray PM; Forster SJ; Carr FJ; Harris WJ
    Protein Eng; 1994 Dec; 7(12):1501-7. PubMed ID: 7716162
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunization with recombinant alpha toxin partially protects broiler chicks against experimental challenge with Clostridium perfringens.
    Cooper KK; Trinh HT; Songer JG
    Vet Microbiol; 2009 Jan; 133(1-2):92-7. PubMed ID: 18635321
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis of peptide based epsilon toxin vaccine by covalent anchoring to tetanus toxoid.
    Kaushik H; Dixit A; Garg LC
    Anaerobe; 2018 Oct; 53():50-55. PubMed ID: 29920342
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gene cloning shows the alpha-toxin of Clostridium perfringens to contain both sphingomyelinase and lecithinase activities.
    Saint-Joanis B; Garnier T; Cole ST
    Mol Gen Genet; 1989 Nov; 219(3):453-60. PubMed ID: 2560137
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Production and properties of theta-toxin of Clostridium perfringens with special reference to lethal activity.
    Soda S; Ito A; Yamamoto A
    Jpn J Med Sci Biol; 1976 Dec; 29(6):335-49. PubMed ID: 192930
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Beta toxin is essential for the intestinal virulence of Clostridium perfringens type C disease isolate CN3685 in a rabbit ileal loop model.
    Sayeed S; Uzal FA; Fisher DJ; Saputo J; Vidal JE; Chen Y; Gupta P; Rood JI; McClane BA
    Mol Microbiol; 2008 Jan; 67(1):15-30. PubMed ID: 18078439
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evidence of the protective immunogenicity of native and recombinant Clostridium haemolyticum phospholipase C (beta toxin) in guinea pigs.
    Hauer PJ; Yeary TJ; Rosenbusch RF
    Vaccine; 2006 Jan; 24(2):124-32. PubMed ID: 16140435
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification and sequence determination of recombinant Clostridium perfringens alpha-toxin by use of electrospray ionization mass spectrometry.
    Saito H; Inoue M; Tomiki M; Nemoto H; Komoriya T; Kimata J; Watanabe K; Kohno H
    Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2009; 20(1-2):9-20. PubMed ID: 20528092
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Production of a non-toxic site-directed mutant of Clostridium perfringens epsilon-toxin which induces protective immunity in mice.
    Oyston PCF; Payne DW; Havard HL; Williamson ED; Titball RW
    Microbiology (Reading); 1998 Feb; 144 ( Pt 2)():333-341. PubMed ID: 9493371
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In silico design and in vitro analysis of a recombinant trivalent fusion protein candidate vaccine targeting virulence factor of Clostridium perfringens.
    Katalani C; Nematzadeh G; Ahmadian G; Amani J; Kiani G; Ehsani P
    Int J Biol Macromol; 2020 Mar; 146():1015-1023. PubMed ID: 31726124
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protection Against Necrotic Enteritis in Broiler Chickens by Regulated Delayed Lysis Salmonella Vaccines.
    Jiang Y; Mo H; Willingham C; Wang S; Park JY; Kong W; Roland KL; Curtiss R
    Avian Dis; 2015 Dec; 59(4):475-85. PubMed ID: 26629620
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sequence variation in the alpha-toxin encoding plc gene of Clostridium perfringens strains isolated from diseased and healthy chickens.
    Abildgaard L; Engberg RM; Pedersen K; Schramm A; Hojberg O
    Vet Microbiol; 2009 May; 136(3-4):293-9. PubMed ID: 19070974
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunochemical and structural similarities in toxin A and toxin B of Clostridium difficile shown by binding to monoclonal antibodies.
    Rothman SW; Gentry MK; Brown JE; Foret DA; Stone MJ; Strickler MP
    Toxicon; 1988; 26(6):583-97. PubMed ID: 2459808
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vaccines against Clostridium perfringens alpha-toxin.
    Nagahama M
    Curr Pharm Biotechnol; 2013; 14(10):913-7. PubMed ID: 24372250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The first strain of Clostridium perfringens isolated from an avian source has an alpha-toxin with divergent structural and kinetic properties.
    Justin N; Walker N; Bullifent HL; Songer G; Bueschel DM; Jost H; Naylor C; Miller J; Moss DS; Titball RW; Basak AK
    Biochemistry; 2002 May; 41(20):6253-62. PubMed ID: 12009886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.